You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 28 No. 3, March 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (83)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Improved Control of Epilepsy by Monitoring Plasma Ethosuximide

Allan L. Sherwin, MD, PhD; J. Preston Robb, MD; Mortimer Lechter, MD

Arch Neurol. 1973;28(3):178-181.


Abstract

Plasma ethosuximide level was monitored in 70 patients with absence (petit mal) seizures. Levels were linearly related to administered dose. Of 37 ambulatory patients with uncontrolled attacks, 38% (14) had levels below the 95% tolerance limit in contrast to 9% (5) of the controlled group. This difference, due to noncompliance with therapy, was eliminated by regular monitoring. Appropriate adjustment of plasma ethosuximide levels resulted in a reduction of seizures in 48% (18) of previously uncontrolled patients. Practical control of epilepsy increased from 64% (45) to 81% (57). Monitoring of plasma ethosuximide increases the effectiveness of therapy by the recognition of noncompliance and the individualization of drug requirements.



Author Affiliations

Montreal

From the Department of Neurology and Neurosurgery, McGill University, the Montreal Neurological Institute, and the Montreal Children's Hospital, Montreal.


Footnotes

Accepted for publication Sept 14, 1972.

Read in part before the annual meeting of the American Neurological Association, Chicago, June 12, 1972.

Reprint requests to Montreal Neurological Institute, 3801 University St, Montreal 112, Canada (Dr. Sherwin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anticonvulsant Blood Levels: Historical Review With a Pediatric Focus
Snodgrass and Parks
J Child Neurol 2000;15:734-746.
ABSTRACT  

Syndromes of Epilepsy in Childhood and Adolescence
Ogunyemi and Dreifuss
J Child Neurol 1988;3:214-224.
ABSTRACT  

Interlaboratory Variability in Determination of Plasma Antiepileptic Drug Concentrations
Pippenger et al.
Arch Neurol 1976;33:351-355.
ABSTRACT  

Usefulness of Blood Levels of Antiepileptic Drugs
Kutt and Penry
Arch Neurol 1974;31:283-288.
ABSTRACT  

Anticonvulsant Drugs in Human Epileptogenic Brain: Correlation of Phenobarbital and Diphenylhydantoin Levels With Plasma
Sherwin et al.
Arch Neurol 1973;29:73-77.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.